Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Vikesh K. Singh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7577-3521; OpenAlex author ID A5085267958. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
68
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: 2 papers · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 5 papers

Papers 13

  1. Pathophysiology, assessment, and treatment of pain in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00535-026-02423-3↗
  2. New-Onset Diabetes: A Window Into Early Pancreatic Cancer Detection? First author DOI 10.1053/j.gastro.2025.09.007↗
  3. Prevalence and Imaging Characteristics of Chronic Calcific Pancreatitis in Patients With Newly Diagnosed Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/rct.0000000000001916↗
  4. Pain profiles in pancreatic cancer and chronic pancreatitis: a multicenter cross-sectional analysis. Co-author DOI 10.3389/fpain.2026.1903789↗
  5. Widespread Hyperalgesia Predicts Mortality in Pancreatic Adenocarcinoma Last author DOI 10.64898/2026.05.19.26353594↗
  6. Pancreatic adenocarcinoma patients with pain have abnormal central pain processing. Last author DOI 10.1016/j.pan.2025.04.010↗
  7. RAD51B Harbors Germline Mutations Associated With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1200/po.21.00404↗
  8. Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017. Co-author DOI 10.1016/j.canlet.2020.10.039↗
  9. Pain in pancreatic ductal adenocarcinoma: A multidisciplinary, International guideline for optimized management. Co-author DOI 10.1016/j.pan.2018.04.008↗
  10. Metastatic Pancreatic Adenocarcinoma in a Patient With Chronic Calcific Pancreatitis and a Heterozygous SPINK1 c.194+2T>C Mutation. Last author DOI 10.1097/mpa.0000000000001015↗
  11. Metastatic pancreatic adenocarcinoma associated with chronic calcific pancreatitis and a heterozygous SPINK1 N34S mutation. Last author DOI 10.1016/j.pan.2016.06.006↗
  12. Differentiating autoimmune pancreatitis from pancreatic adenocarcinoma using dual-phase computed tomography. First author DOI 10.1097/rct.0b013e3182a9a431↗
  13. Comparative analysis of traditional and coiled fiducials implanted during EUS for pancreatic cancer patients receiving stereotactic body radiation therapy. Co-author DOI 10.1016/j.gie.2012.07.006↗

Closest collaborators

The 25 strongest of 68 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Søren Schou Olesen · 6 shared papers, 2018–2026 · strength 1.73
  2. Mahya Faghih · 5 shared papers, 2025–2026 · strength 1.28
  3. Asbjørn Mohr Drewes · 5 shared papers, 2018–2026 · strength 1.10
  4. Marko Damm · 4 shared papers, 2025–2026 · strength 1.03
  5. Daniel A. Laheru · 6 shared papers, 2016–2026 · strength 0.98
  6. Marie-Theres Kassik · 3 shared papers, 2026 · strength 0.80
  7. Anna Evans Phillips · 3 shared papers, 2025–2026 · strength 0.75
  8. Dhiraj Yadav · 3 shared papers, 2025–2026 · strength 0.75
  9. Jonas Rosendahl · 3 shared papers, 2025–2026 · strength 0.75
  10. Lei Zheng · 4 shared papers, 2021–2026 · strength 0.67
  11. Atif Zaheer · 5 shared papers, 2014–2026 · strength 0.56
  12. Sophie Rauschenberg · 2 shared papers, 2026 · strength 0.52
  13. Anne Marie Lennon · 5 shared papers, 2012–2022 · strength 0.35
  14. Satomi Kawamoto · 2 shared papers, 2014–2026 · strength 0.30
  15. Michael Hirth · 1 shared paper, 2026 · strength 0.28
  16. Patrick Michl · 1 shared paper, 2026 · strength 0.28
  17. Mouen A. Khashab · 4 shared papers, 2012–2022 · strength 0.26
  18. Zahra Yousefli · 1 shared paper, 2026 · strength 0.25
  19. Rubab F. Malik · 1 shared paper, 2026 · strength 0.25
  20. Richard Andrew Burkhart · 1 shared paper, 2026 · strength 0.25
  21. Jin He · 1 shared paper, 2026 · strength 0.25
  22. Elham Afghani · 1 shared paper, 2026 · strength 0.25
  23. Elliot K. Fishman · 3 shared papers, 2014–2022 · strength 0.23
  24. Eun Ji Shin · 3 shared papers, 2012–2022 · strength 0.21
  25. Robert A. Anders · 2 shared papers, 2021–2022 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.